Showing 1 - 20 results of 39 for search '"neurodegeneration"', query time: 0.10s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Dise... by Julia Doroszkiewicz, Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Renata Borawska, Monika Zajkowska, Agnieszka Słowik, Barbara Mroczko

    Published 2023-07-01
    “…A transmembrane glycoprotein known as glycoprotein nonmetastatic melanoma protein B (GPNMB) plays a neuroprotective role during the development of neurodegeneration. To the best of our knowledge, this is the first investigation discussing the potential clinical usefulness of this protein in the AD continuum, especially in the MCI (mild cognitive impairment) stage. …”
    Get full text
    Article
  6. 6

    Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease by Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, Renata Borawska, Barbara Mroczko

    Published 2021-10-01
    “…Synaptic loss and dysfunction are one of the earliest signs of neurodegeneration associated with cognitive decline in Alzheimer’s disease (AD). …”
    Get full text
    Article
  7. 7

    Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis by Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Renata Borawska, Agnieszka Słowik, Barbara Mroczko

    Published 2022-09-01
    “…Synaptic loss and dysfunction are one of the earliest signs of neurodegeneration associated with cognitive decline in Alzheimer’s disease (AD) and other neurodegenerative diseases. …”
    Get full text
    Article
  8. 8

    The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches by Agnieszka Kulczyńska-Przybik, Piotr Mroczko, Maciej Dulewicz, Barbara Mroczko

    Published 2021-04-01
    “…Moreover, RTNs, particularly RTN4 and RTN3, are involved in neurodegeneration and neuroinflammation processes. The crucial role of RTNs in the development of several neurodegenerative diseases, including Alzheimer’s disease (AD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or other neurological conditions such as brain injury or spinal cord injury, has attracted scientific interest. …”
    Get full text
    Article
  9. 9

    Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease by Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, Renata Borawska, Barbara Mroczko

    Published 2021-07-01
    “…The ApoE4 and FABP3 proteins may reflect processes leading to neurodegeneration. This study aimed to evaluate the relationship between the CSF levels of FABP3 and ApoE4 proteins and cognitive decline as well as the diagnostic performance of these candidate biomarkers in AD and mild cognitive impairment (MCI). …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System by Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko

    Published 2021-09-01
    “…We present recent findings concerning the effect of the altered microbiota on neurodegeneration and neuroinflammation, including Alzheimer’s and Parkinson’s diseases, as well as multiple sclerosis. …”
    Get full text
    Article
  18. 18
  19. 19
  20. 20